The Role of the Diabetes Care and Education Specialist in Caring for Diabetes Complications and Common Comorbid Conditions

Iglay K Hannachi H Howie PJ , et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243-1252.

McElwee-Malloy M. Reducing risks. In: Cornell S Halstenson C Miller DK eds. The Art and Science of Diabetes Care and Education. 5th ed. Association of Diabetes Care and Education; 2015:265.pages 285-326.

American Diabetes Association. Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1).

American Association of Diabetes Educators. An effective model of diabetes care and education: revising the AADE7 Self-Care Behaviors®. Diabetes Educ. 2020;46(2):139-160.

Powers MA Bardsley JK Cypress M , et al. Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care. 2020;43(7):1636-1649.

Dei Cas A Khan SS Butler J , et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail. 2015;3(2):136-45. doi:10.1016/j.jchf.2014.08.004

Einarson TR Acs A Ludwig C Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6

de Ferranti SD de Boer IH Fonseca V , et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2014;37(10):2843-2863. doi:10.2337/dc14-1720

Ryan D Burke SD Litchman ML , et al. Competencies for diabetes care and education specialists. Diabetes Educ. 2020;46(4):384-397. doi:10.1177/0145721720931092

Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.

Low Wang CC Hess CN Hiatt WR Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459-2502. doi:10.1161/CIRCULATIONAHA.116.022194

Association of Diabetes Care and Education Specialists. Addressing obesity in diabetes. 2018. Accessed March 5, 2021. https://www.diabeteseducator.org/docs/default-source/practice/practice-documents/practice-papers/addressing-obesity-in-diabetes.pdf

Arnett DK Blumenthal RS Albert MA , et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646.

Grundy SM Stone NJ Bailey AL , et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ ASPC/NLA/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350.

Whelton PK Carey RM Aronow WS , et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e127-e248.

Centers for Disease Control and Prevention. Facts about hypertension. Accessed June 21, 2020. https://www.cdc.gov/bloodpressure/facts.htm

de Boer IH Bangalore S Benetos A , et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(9):1273-1284. doi:10.2337/dci17-0026.

American Heart Association. Why high blood pressure is a “silent killer.” Accessed July 25, 2020. https://www.heart.org/en/health-topics/high-blood-pressure/why-high-blood-pressure-is-a-silent-killer

Yancy CW Jessup M Bozkurt B , et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-e239.

Benjamin EJ Muntner P Alonso A , et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.

Nichols GA Gullion CM Koro CE Ephross SA Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879-1884.

Native M Potier L Alexandre L , et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol. 2018;17(1):138.

Gerhard-Herman MD Gornik HL Barrett C , et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726-e779.

Agency for Healthcare Research and Quality. Evidence-based practice center systematic review protocol. January 31, 2013. Accessed July 20, 2020. https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf

Shimbo D Artinian NT Basile JN , et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142:e42-e63. doi:10.1161/CIR.0000000000000803

Beckman JA Creager MA. Vascular complications of diabetes. Circ Res. 2016;118(11):1771-1785.

Cha AE Villarroel MA Vahratian A. Eye Disorders and Vision Loss Among U.S. Adults Aged 45 and Over With Diagnosed Diabetes, 2016–2017. NCHS Data Brief, no 344. National Center for Health Statistics; 2019.

Flaxel CJ Adelman RA Bailey ST , et al. Diabetic retinopathy preferred practice pattern®. Ophthalmology. 2020;127(1):P66-P145.

Lueder GT Silverstein J ; American Academy of Pediatrics Section on Ophthalmology and Section on Endocrinology. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116(1):270-273.

Geloneck MM Forbes BJ Shaffer J Ying GS Binenbaum G. Ocular complications in children with diabetes mellitus. Ophthalmology. 2015;122(12):2457-2464.

Centers for Disease Control and Prevention Vision Health Initiative. Economic studies: cost-effectiveness model for diabetic retinopathy. Reviewed April 11, 2017. Accessed July 10, 2020. https://www.cdc.gov/visionhealth/projects/economic_studies.htm

Centers for Disease Control and Prevention Vision Health Initiative. Fast facts of common eye disorders. Reviewed June 9, 2020. Accessed July 10, 2020. https://www.cdc.gov/visionhealth/basics/ced/fastfacts.htm

Ioannidou E Tseriotis VS Tziomalos K. Role of lipid-lowering agents in the management of diabetic retinopathy. World J Diabetes. 2017;8(1):1-6.

Antonetti DA Klein R Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227-1239.

Evert AB Dennison M Gardner CD , et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42(5):731-754.

Perkovic V Jardine MJ Neal B , et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295-2306.

Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33(2):434-441. doi:10.2337/dc09-1294

Balcıoğlu AS Müderrisoğlu H. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015;6(1):80-91. doi:10.4239/wjd.v6.i1.80

Agashe S Petak S. Cardiac autonomic neuropathy in diabetes mellitus. Methodist Debakey Cardiovasc J. 2018;14(4):251-256. doi:10.14797/mdcj-14-4-251.

Vinik AI Casellini C Parson HK Colberg SR Nevoret ML. Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events. Front Neurosci. 2018;12:591. doi:10.3389/fnins.2018.00591

Avalos DJ Sarosiek I Loganathan P McCallum RW. Diabetic gastroparesis: current challenges and future prospects. Clin Exp Gastroenterol. 2018;11:347-363. doi:10.2147/CEG.S131650

Baker J. Gastroparesis management. AADE in Practice. 2017;5(2):38-42.

Trulicity (dulaglutide). Package insert. Eli Lilly and Company; 2017.

Byetta (exenatide). Package insert. AstraZeneca Pharmaceuticals LP; 2018.

Braffett BH Wessells H Sarma AV. Urogenital autonomic dysfunction in diabetes. Curr Diab Rep. 2016;16(12):119. doi:10.1007/s11892-016-0824-5

Maiorino MI Bellastella G Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes. 2014;7:95-105. doi:10.2147/DMSO.S36455

Wittig L Carlson KV Andrews JM Crump RT Baverstock RJ. Diabetic bladder dysfunction: a review. Urology. 2019;123:1-6. doi:10.1016/j.urology.2018.10.010

Giraldi A Kristensen E. Sexual dysfunction in women with diabetes mellitus. J Sex Res. 2010;47(2):199-211. doi:10.1080/00224491003632834

Spravchikov N Sizyakov G Gartsbein M Accili D Tennenbaum T Wertheimer E. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes. 2001;50(7):1627-1635. doi:10.2337/diabetes.50.7.1627

Lotfy M Adeghate J Kalasz H Singh J Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2017;13(1):3-10. doi:10.2174/1573399812666151016101622

Skin complications | ADA. Accessed July 27, 2020. https://www.diabetes.org/diabetes/complications/skin-complications

Messer LH Berget C Beatson C Polsky S Forlenza GP. Preserving skin integrity with chronic device use in diabetes. Diabetes Technol Ther. 2018;20(S2):S254-S264. doi:10.1089/dia.2018.0080

Makrantonaki E Jiang D Hossini AM , et al. Diabetes mellitus and the skin. Rev Endocr Metab Disord. 2016;17(3):269-282. doi:10.1007/s11154-016-9373-0

Mendes AL Miot HA Haddad V Jr. Diabetes mellitus and the skin. An Bras Dermatol. 2017;92(1):8-20. doi:10.1590/abd1806-4841.20175514

Gupta S Eavey RD Wang M Curhan SG Curhan GC. Type 2 diabetes and the risk of incident hearing loss. Diabetologia. 2019;62(2):281-285. doi:10.1007/s00125-018-4766-0

Olusanya BO Neumann KJ Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ. 2014;92(5):367-373. doi:10.2471/BLT.13.128728

Diniz TH Guida HL. Hearing loss in patients with diabetes mellitus. Braz J Otorhinolaryngol. 2009;75(4):573-578. doi:10.1016/s1808-8694(15)30498-5

Chandrasekhar SS Tsai Do BS Schwartz SR , et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(1 suppl):S1-S45. doi:10.1177/0194599819859885

Spankovich C Yerraguntla K. Evaluation and management of patients with diabetes and hearing loss. Semin Hear. 2019;40(4):308-314. doi:10.1055/s-0039-1697644

Hearing loss and diabetes. Accessed July 27, 2020. https://www.asha.org/Articles/Hearing-Loss-and-Diabetes/

Juster-Switlyk K Smith AG. Updates in diabetic peripheral neuropathy. F1000Res. 2016;5:F1000 Faculty Rev-738. doi:10.12688/f1000research.7898.1

Iqbal Z Azmi S Yadav R , et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828-849. doi:10.1016/j.clinthera.2018.04.001

Centre for Clinical Practice at NICE (UK). Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-Specialist Settings. National Institute for Health and Care Excellence (UK); 2013.

Pop-Busui R Boulton AJ Feldman EL , et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154. doi:10.2337/dc16-2042

Sanz M Ceriello A Buysschaert M , et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018;137:231-241. doi:10.1016/j.diabres.2017.12.001

Smiley CJ Tracy SL Abt E , et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015;146(7):525-535. doi:10.1016/j.adaj.2015.01.026

Brown JA Jornsay DL Lavin-Tompkins J , et al. Diabetes and oral health. Panel discussion at: AADE Thought Leader Summit; April 5, 2016.

Leoni S Tovoli F Napoli L Serio I Ferri S Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24(30):3361-3373. doi:10.3748/wjg.v24.i30.3361

Non-alcoholic fatty liver disease (NAFLD): assessment and management | guidance |. Accessed July 19, 2020. https://www.nice.org.uk/guidance/NG49/chapter/Recommendations

Chalasani N Younossi Z Lavine JE , et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357. doi:10.1002/hep.29367

Owens-Gary MD Zhang X Jawanda S , et al. The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med. 2019;34:320-324.

Suvisaari J Perälä J Saarni SI , et al. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci. 2008;258:129-136.